Innovation & intellectual property · 07/07/2004Updated: 10/17/2026 · 1 min read
Grant of Interim Extension of the Term of U.S. Patent No. 4,591,585; Atamestane
Summary
The United States Patent and Trademark Office has granted a one-year extension to the term of U.S. Patent No. 4,591,585, allowing Atamestane to continue its patent protection for an additional year.
Original source language: Federal Register — Patent and Trademark OfficeOpen original release →